PEN vs ABT: Which Stock is Better?
Side-by-side comparison of Penumbra Inc and Abbott Laboratories in 2026
PEN
Penumbra Inc
—
ABT
Abbott Laboratories
$89.00
Key Metrics Comparison
| Metric | PEN | ABT | Winner |
|---|---|---|---|
| Market Cap | $9.93B | $154.15B | ABT |
| P/E Ratio | 237.44 | 24.79 | ABT |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PEN
Full quant analysis
Analyze ABT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PEN or ABT a better investment?
Comparing PEN and ABT: Penumbra Inc has a market cap of $9.93B while Abbott Laboratories has $154.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PEN and ABT?
PEN (Penumbra Inc) and ABT (Abbott Laboratories) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PEN or ABT?
Based on P/E ratios, ABT trades at a lower multiple (24.8x vs 237.4x).
Which is growing faster: PEN or ABT?
Both PEN and ABT show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PEN or ABT?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PEN or ABT?
Abbott Laboratories (ABT) is larger with a market cap of $154.15B compared to $9.93B for PEN.
Should I buy PEN or ABT in 2026?
Both PEN and ABT have investment merit. PEN trades at $N/A while ABT trades at $89.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PEN and ABT stock?
Key differences: Market Cap ($9.93B vs $154.15B), P/E Ratio (237.4x vs 24.8x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PEN or ABT in 2026?
The choice between PEN and ABT depends on your investment goals. ABT shows higher revenue growth (0.0%). ABT has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PEN and ABT?
PEN (Penumbra Inc) has a market cap of $9.93B, while ABT (Abbott Laboratories) has a market cap of $154.15B. ABT is the larger company by market value.